$66.49 +1.47 (%) AbbVie Inc - NYSE

Apr. 28, 2015 | 04:02 PM

Partner Headlines

  1. Obama's Regulators Take Harder Line On Tech Takeovers

    IBD | Apr. 27, 2015 | 18:22PM EST
  2. 4 Top-Rated Drugmakers Reporting Earnings This Week

    IBD | Apr. 26, 2015 | 08:02AM EST
  3. AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

    GuruFocus | Apr. 24, 2015 | 14:05PM EST
  4. Biogen Earnings Preview: What To Look For

    IBD | Apr. 23, 2015 | 19:45PM EST
  5. AbbVie Tops, Alexion Misses

    IBD | Apr. 23, 2015 | 18:42PM EST
  6. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  7. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  8. AbbVie Beats Q1 Views, Raises Earnings Outlook

    Benzinga | Apr. 23, 2015 | 09:31AM EST
  9. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  10. Forget Google: 5 Top Stocks With Earnings Thursday

    IBD | Apr. 22, 2015 | 19:31PM EST
  11. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 16:35PM EST
  12. St. Jude, Abbott Labs Beat Q1 Expectations

    IBD | Apr. 22, 2015 | 10:54AM EST
  13. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  14. Morningstar: Gilead Sciences To Grow Its Hepatitis C Market

    Benzinga | Apr. 18, 2015 | 11:20AM EST
  15. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  16. New drug trial results positive

    IBD | Apr. 15, 2015 | 18:38PM EST
  17. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  18. Solar ETFs Light The Way As Equities Post Broad Gains

    IBD | Apr. 14, 2015 | 18:32PM EST
  19. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 17:48PM EST
  20. Why Johnson & Johnson's Strong Pharmaceutical Business Is A Concern

    Benzinga | Apr. 14, 2015 | 14:45PM EST
  21. J&J Earnings Beat Estimates; Guidance Mixed

    IBD | Apr. 14, 2015 | 11:12AM EST
  22. AbbVie

    IBD | Apr. 13, 2015 | 18:53PM EST
  23. Chinese Stocks Lead Stock Market Higher

    IBD | Apr. 13, 2015 | 12:03PM EST
  24. AbbVie Upgraded On $7.8 Billion Imbruvica Potential

    IBD | Apr. 13, 2015 | 11:19AM EST
  25. Benzinga's Top Upgrades

    Benzinga | Apr. 13, 2015 | 09:08AM EST
  26. Here's Why Imbruvica Caused BMO To Upgrade AbbVie

    Benzinga | Apr. 13, 2015 | 09:04AM EST
  27. BMO Capital Upgrades AbbVie To Outperform

    Benzinga | Apr. 13, 2015 | 08:03AM EST
  28. Pioneer Fundamental Growth Fund: Why Is It Revving Up?

    IBD | Mar. 3, 2015 | 17:22PM EST
  29. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  30. Making Money With Charles Payne: 02/25/15

    FoxBusiness | Feb. 25, 2015 | 18:00PM EST
  31. Heavy News Day For Several Biotech Stocks

    Benzinga | Feb. 25, 2015 | 15:34PM EST
  32. Catalysts AbbVie Investors Need To Watch

    Benzinga | Feb. 24, 2015 | 18:28PM EST
  33. UPDATE: Results from AbbVie's Study of VIEKIRA PAK

    Benzinga | Feb. 23, 2015 | 11:05AM EST
  34. Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepat

    Benzinga | Feb. 23, 2015 | 11:05AM EST
  35. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  36. CNBC's Stock Pops & Drops From February 20

    Benzinga | Feb. 22, 2015 | 20:26PM EST
  37. Dogs Of The S&P 500 - No Dividend Alternatives Are Cheaper!

    GuruFocus | Feb. 21, 2015 | 22:55PM EST
  38. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  39. Soros Fund Management Sells American Express & Netflix, Buys FireEye In Q4

    Benzinga | Feb. 17, 2015 | 17:25PM EST
  40. Biotech Performance 'Particularly Impressive,' Says JP Morgan

    Benzinga | Feb. 17, 2015 | 13:30PM EST
  41. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD | Feb. 13, 2015 | 18:08PM EST
  42. Shire Moves Higher On NPS Potential; Q4 Earnings Miss

    IBD | Feb. 12, 2015 | 10:45AM EST
  43. US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data

    Benzinga | Feb. 12, 2015 | 07:30AM EST
  44. Deutsche Bank's 7 Reasons AbbVie Is Still A Buy

    Benzinga | Feb. 11, 2015 | 12:54PM EST
  45. Achillion Pharmaceuticals Stock Soars Following Successful Mid-Stage Hep C Drug Combo Trial

    GuruFocus | Feb. 10, 2015 | 12:36PM EST
  46. Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown

    Benzinga | Feb. 9, 2015 | 11:46AM EST
  47. UPDATE: Citi Initiates Coverage On AbbVie, Sees Price Erosion Ahead

    Benzinga | Feb. 9, 2015 | 09:45AM EST
  48. Benzinga's Top Initiations

    Benzinga | Feb. 9, 2015 | 09:25AM EST
  49. Citigroup Initiates AbbVie With Sell

    Benzinga | Feb. 9, 2015 | 08:38AM EST
  50. Barron's Recap: This Man Made, Lost And Made A Fortune Investing In Russia

    Benzinga | Feb. 8, 2015 | 11:09AM EST
Trading Center